MAIA Biotechnology enrolls first patient in expansion of phase 2 clinical trial for ateganosine in advanced non-small cell lung cancer: Chicago Friday, July 11, 2025, 12:00 Hrs [I ...

Delhi High Court asks CCSEA to conduct inspection on Palamur Biosciences: Our Bureau, New Delhi Friday, July 11, 2025, 11:30 Hrs [IST] The Delhi High Court has asked the Committee ...

Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...

Lone Tree, Colorado Thursday, July 10, 2025, 13:00 Hrs [IST] ...

MedTech zone innovative programme selected for BRICS+ Global Initiative: Our Bureau, Mumbai Thursday, July 10, 2025, 14:20 ...

Small pharma cos struggle with revised Schedule M compliance amid resource & expertise gaps: Harish Jain: Nandita Vijayasimha, Bengaluru Friday, July 11, 2025, 08:00 Hrs [IST] Sma ...

Karnataka and Germany sign MoU to strengthen ties in lifesciences start-ups: Nandita Vijayasimha, Bengaluru Friday, July 11, 2025, 08:00 Hrs [IST] ed by Minister M?B?Patil and Dr?

The Central Drugs Standard Control Organisation (CDSCO) has published a prerequisite form for the industry members to fill in for the walk-in meeting with the Drugs Controller General of India (DCGI) ...

In a move aimed at boosting pharma exports and enhancing transparency in international trade, the Directorate General of Foreign Trade (DGFT) has announced the introduction of new Standard Input ...

Eight TN firms win ‘Brand Impact Awards 2025’ instituted by TN IDMA: Peethaambaran Kunnathoor, Chennai Friday, July 11, 2025, 08:00 Hrs [IST] Eight prominent pharma companies ...

ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025: London, UK Thursday, July 10, 2025, 15:00 ...

Verified Clinical Trials begins ops in Japan in partnership with MRJ & JACIC to prevent duplicate and professional subjects in clinical trials: Tokyo Thursday, July 10, 2025, 18:0 ...